Free Trial

CRH (CRH) Stock Forecast & Price Target

CRH logo
$93.71 -3.52 (-3.62%)
(As of 12/18/2024 05:45 PM ET)

CRH - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
12

Based on 13 Wall Street analysts who have issued ratings for CRH in the last 12 months, the stock has a consensus rating of "Buy." Out of the 13 analysts, 1 has given a hold rating, 11 have given a buy rating, and 1 has given a strong buy rating for CRH.

Consensus Price Target

$106.42
13.56% Upside
According to the 13 analysts' twelve-month price targets for CRH, the average price target is $106.42. The highest price target for CRH is $120.00, while the lowest price target for CRH is $82.00. The average price target represents a forecasted upside of 13.56% from the current price of $93.71.
Get the Latest News and Ratings for CRH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CRH and its competitors.

Sign Up

CRH Analyst Ratings Over Time

TypeCurrent Forecast
12/20/23 to 12/19/24
1 Month Ago
11/20/23 to 11/19/24
3 Months Ago
9/21/23 to 9/20/24
1 Year Ago
12/20/22 to 12/20/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
10 Buy rating(s)
8 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$106.42$105.55$95.70$55.38
Forecasted Upside13.56% Upside5.77% Upside3.07% Upside-17.45% Downside
Consensus Rating
Buy
Buy
Moderate Buy
Moderate Buy

CRH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CRH Stock vs. The Competition

TypeCRHConstruction CompaniesS&P 500
Consensus Rating Score
3.00
2.61
2.51
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside13.56% Upside21.53% Upside15.36% Upside
News Sentiment Rating
Positive News

See Recent CRH News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/20/2024JPMorgan Chase & Co.
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$114.00 ➝ $116.00+16.24%
11/11/2024Hsbc Global Res
0 of 5 stars
B. Siya
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
11/11/2024HSBC
2 of 5 stars
 Initiated CoverageBuy$116.00+13.41%
11/11/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$110.00 ➝ $120.00+18.19%
11/11/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$95.00 ➝ $104.00+3.31%
11/8/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$110.00 ➝ $120.00+19.49%
10/29/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Seiden
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$110.00+16.54%
7/11/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$109.00 ➝ $99.00+25.21%
6/18/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Grooms
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$95.00+20.68%
5/14/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$110.00+33.95%
4/15/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold$80.00 ➝ $82.00-0.53%
3/22/2024Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$105.00+22.42%
3/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$89.70 ➝ $100.00+19.62%
11/6/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$58.00+1.97%
6/15/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$6.50-87.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:39 AM ET.


Should I Buy CRH Stock? CRH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these CRH pros and cons to contact@marketbeat.com.

CRH
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in CRH plc:

  • Recent upgrades from major financial institutions, including JPMorgan Chase & Co. raising their price target to $116.00, indicate strong confidence in CRH plc's growth potential.
  • The stock has a consensus rating of "Buy" from analysts, suggesting that the majority believe it is a good investment opportunity.
  • CRH plc's current stock price is $98.85, which is below the average target price of $106.42, presenting a potential buying opportunity for investors looking for value.
  • The company has a solid market capitalization of $67.14 billion, which reflects its stability and ability to weather market fluctuations.
  • CRH plc has a relatively low payout ratio of 37.20%, indicating that it retains a significant portion of its earnings for reinvestment, which can drive future growth.

CRH
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in CRH plc for these reasons:

  • Despite recent upgrades, the stock has experienced a decline of 1.2%, which may indicate underlying market concerns or volatility.
  • The company recently cut its dividend, which could signal financial strain or a shift in strategy that may not favor shareholders in the short term.
  • CRH plc's beta of 1.29 suggests that the stock is more volatile than the market, which could lead to higher risk for investors.
  • The stock's 1-year high of $104.23 is relatively close to its current price, limiting potential upside for new investors.
  • With only one analyst rating the stock as a hold, there may be a lack of consensus on its future performance, which could lead to uncertainty for potential investors.

CRH Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for CRH is $106.42, with a high forecast of $120.00 and a low forecast of $82.00.

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CRH in the last twelve months. There is currently 1 hold rating, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRH shares.

According to analysts, CRH's stock has a predicted upside of 13.56% based on their 12-month stock forecasts.

Over the previous 90 days, CRH's stock had 1 upgrade by analysts.

CRH has been rated by research analysts at Barclays, DA Davidson, Hsbc Global Res, HSBC, JPMorgan Chase & Co., Morgan Stanley, and Truist Financial in the past 90 days.

Analysts like CRH more than other "construction" companies. The consensus rating for CRH is Buy while the average consensus rating for "construction" companies is Moderate Buy. Learn more on how CRH compares to other companies.


This page (NYSE:CRH) was last updated on 12/19/2024 by MarketBeat.com Staff
From Our Partners